Assignee
GENENTECH INC
US·2,896 granted patents·2,780 pending applications·141,475 citations·filing 1979–2025
Top patents by PatentIndex Score
5,676 records- 0199US7862817B2Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2005·Granted Jan 4, 2011·126 cites·23 claims
- 0299US7695936B2Knobs and holes heteromeric polypeptidesGENENTECH INC·Filed 2006·Granted Apr 13, 2010·817 cites·73 claims
- 0399US7642228B2Method for making heteromultimeric polypeptidesGENENTECH INC·Filed 2001·Granted Jan 5, 2010·404 cites·40 claims
- 0499US7537931B2Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodiesGENENTECH INC·Filed 2006·Granted May 26, 2009·83 cites·24 claims
- 0599US7501122B2Treatment with anti-ErbB2 antibody combinationsGENENTECH INC·Filed 2005·Granted Mar 10, 2009·76 cites·9 claims
- 0699US7498030B2Treatment with anti-ErbB2 antibodies and anti-hormonal compoundsGENENTECH INC·Filed 2005·Granted Mar 3, 2009·69 cites·14 claims
- 0799US7485302B2Treatment with anti-ErbB2 antibodies and chemotherapeutic agentsGENENTECH INC·Filed 2006·Granted Feb 3, 2009·109 cites·30 claims
- 0899US7371826B2Polypeptide variants with altered effector functionGENENTECH INC·Filed 2006·Granted May 13, 2008·1.1k cites·7 claims
- 0999US7365166B2Anti-VEGF antibodiesGENENTECH INC·Filed 2006·Granted Apr 29, 2008·90 cites·7 claims
- 1099US7335742B2Polypeptide variants with altered effector functionGENENTECH INC·Filed 2006·Granted Feb 26, 2008·167 cites·10 claims
- 1199US7332581B2Polypeptide variants with altered effector functionGENENTECH INC·Filed 2005·Granted Feb 19, 2008·1.2k cites·19 claims
- 1299US7183387B1Polypeptide variants with altered effector functionGENENTECH INC·Filed 2000·Granted Feb 27, 2007·223 cites·7 claims
- 1399US7169901B2Anti-VEGF antibodiesGENENTECH INC·Filed 2002·Granted Jan 30, 2007·160 cites·12 claims
- 1499US7122637B2Polypeptide variants with altered effector functionGENENTECH INC·Filed 2004·Granted Oct 17, 2006·188 cites·7 claims
- 1599US7060269B1Anti-VEGF antibodiesGENENTECH INC·Filed 2000·Granted Jun 13, 2006·342 cites·2 claims
- 1699US6998253B1Altered polypeptides with increased half-lifeGENENTECH INC·Filed 2000·Granted Feb 14, 2006·250 cites·11 claims
- 1799US6949245B1Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2000·Granted Sep 27, 2005·317 cites·24 claims
- 1899US6884879B1Anti-VEGF antibodiesGENENTECH INC·Filed 1997·Granted Apr 26, 2005·623 cites·14 claims
- 1999US6800738B1Method for making humanized antibodiesGENENTECH INC·Filed 2000·Granted Oct 5, 2004·274 cites·13 claims
- 2099US6737056B1Polypeptide variants with altered effector functionGENENTECH INC·Filed 2000·Granted May 18, 2004·3.4k cites·33 claims
- 2199US6719971B1Method for making humanized antibodiesGENENTECH INC·Filed 2000·Granted Apr 13, 2004·393 cites·5 claims
- 2299US6639055B1Method for making humanized antibodiesGENENTECH INC·Filed 2000·Granted Oct 28, 2003·523 cites·3 claims
- 2399US6582959B2Antibodies to vascular endothelial cell growth factorGENENTECH INC·Filed 1997·Granted Jun 24, 2003·283 cites·4 claims
- 2499US6407213B1Method for making humanized antibodiesGENENTECH INC·Filed 1992·Granted Jun 18, 2002·2.2k cites·82 claims
- 2599US6399063B1Monoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1998·Granted Jun 4, 2002·282 cites·18 claims
- 2699US6387371B1Monoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1999·Granted May 14, 2002·272 cites·14 claims
- 2799US6165464AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1998·Granted Dec 26, 2000·363 cites·11 claims
- 2899US6121022AAltered polypeptides with increased half-lifeGENENTECH INC·Filed 1995·Granted Sep 19, 2000·1.2k cites·23 claims
- 2999US6054297AHumanized antibodies and methods for making themGENENTECH INC·Filed 1995·Granted Apr 25, 2000·2.3k cites·30 claims
- 3099US5869046AAltered polypeptides with increased half-lifeGENENTECH INC·Filed 1995·Granted Feb 9, 1999·2.5k cites·7 claims
- 3199US5834250AMethod for identifying active domains and amino acid residues in polypeptides and hormone variantsGENENTECH INC·Filed 1997·Granted Nov 10, 1998·432 cites·31 claims
- 3299US5821337AImmunoglobulin variantsGENENTECH INC·Filed 1992·Granted Oct 13, 1998·4k cites·15 claims
- 3399US5821333AMethod for making heteromultimeric polypeptidesGENENTECH INC·Filed 1995·Granted Oct 13, 1998·681 cites·27 claims
- 3499US5807706AMethod for making heteromultimeric polypeptidesGENENTECH INC·Filed 1995·Granted Sep 15, 1998·587 cites·26 claims
- 3599US5772997AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1995·Granted Jun 30, 1998·437 cites·13 claims
- 3699US5770195AMonoclonal antibodies directed to the her2 receptorGENENTECH INC·Filed 1995·Granted Jun 23, 1998·492 cites·36 claims
- 3799US5739277AAltered polypeptides with increased half-lifeGENENTECH INC·Filed 1995·Granted Apr 14, 1998·980 cites·3 claims
- 3899US5731168AMethod for making heteromultimeric polypeptidesGENENTECH INC·Filed 1995·Granted Mar 24, 1998·2.6k cites·41 claims
- 3999US5725856AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1995·Granted Mar 10, 1998·516 cites·26 claims
- 4099US5720954AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1995·Granted Feb 24, 1998·328 cites·35 claims
- 4199US5677171AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1994·Granted Oct 14, 1997·924 cites·39 claims
- 4299US5648237AExpression of functional antibody fragmentsGENENTECH INC·Filed 1995·Granted Jul 15, 1997·1.5k cites·47 claims
- 4399US5428130AHybrid immunoglobulinsGENENTECH INC·Filed 1992·Granted Jun 27, 1995·861 cites·23 claims
- 4499US5364934APlasma carboxypeptidaseGENENTECH INC·Filed 1993·Granted Nov 15, 1994·367 cites·5 claims
- 4599US5225538ALymphocyte homing receptor/immunoglobulin fusion proteinsGENENTECH INC·Filed 1991·Granted Jul 6, 1993·592 cites·29 claims
- 4699US5175273ANucleic acid intercalating agentsGENENTECH INC·Filed 1988·Granted Dec 29, 1992·1.3k cites·19 claims
- 4799US5116964AHybrid immunoglobulinsGENENTECH INC·Filed 1989·Granted May 26, 1992·1.4k cites·8 claims
- 4898US8785626B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Jul 22, 2014·54 cites·4 claims
- 4998US8030023B2Nucleic acid encoding DR5 antibodies and uses thereofGENENTECH INC·Filed 2006·Granted Oct 4, 2011·56 cites·8 claims
- 5098US7799900B2Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Granted Sep 21, 2010·103 cites·19 claims
Showing the top 50 of 5,676 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →